Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy
2018
BackgroundThe role of antiviral prophylaxis before chemotherapy or immunosuppressive therapy to prevent hepatitis B virus (HBV) reactivation in patients with resolved HBV infection [hepatitis B surface antigen (HBsAg) negative, hepatitis B core antibody (anti-HBc) positive] is unclear. This study ai
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
18
References
13
Citations
NaN
KQI